RhumbLine Advisers’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
RhumbLine Advisers's ANRO Position: Q3 2026 in Review
RhumbLine Advisers increased its Alto Neuroscience (ANRO) stake by 18% in Q3 2026, buying an estimated $175K and bringing the position to 37,463 shares worth $956K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.
RhumbLine Advisers first reported a position in ANRO in Q2 2024 and has held it in 6 quarters since. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- RhumbLine Advisers held 37,463 shares of Alto Neuroscience worth $956K as of Q3 2026.
- RhumbLine Advisers bought 5,827 Alto Neuroscience shares in Q3 2026, an estimated $175K.
- Alto Neuroscience made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2299 holding.
- RhumbLine Advisers first reported a position in Alto Neuroscience in Q2 2024 and has held it in 6 quarters since.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.